Clinical trial
Subcutaneous (SC) Interferon Beta Therapy in Multiple Sclerosis Patients and Characterization of Injection Site Reactions and Flu-Like Symptoms Under Daily Practice Setting
NCT03347370 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Subcutaneous (SC) Interferon Beta Therapy in Multiple Sclerosis Patients and Characterization of Injection Site Reactions and Flu-Like Symptoms Under Daily Practice Setting
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 27, 2017
- Completion date
- July 31, 2019
- Enrollment
- 626 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.